Finasteride – Solution, 5mg/mL @ 30mL

Finasteride – Solution, 5mg/mL @ 30mL

$40.00 $20.00

Concentration: 5mg per mL, 150mg/30mL total; includes 1mL pipette.

Out of stock - Join the waitlist to be emailed when this product becomes available

000

Read the Specification Before Buying:

Application 5-alpha Reductase Inhibitor
CAS 98319-26-7
Molar Mass 372.55 g/mol
Chemical Formula C23H36N2O2
Chemical Name (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-1H,2H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H,11H,11aH-indeno[5,4-f]quinoline-7-carboxamide
Synonyms Finasteride, 98319-26-7, Finastid, Prostide, Chibro-Proscar, MK-906, Finasterida, Finasteridum, Finpecia, Finasteridum [INN-Latin], Finasterida [INN-Spanish], MK 906, Andozac, UNII-57GNO57U7G, Propecia (TN), Proscar (TN), MK 0906, MK-0906, Finasteride [USAN:INN:BAN], CCRIS 7438, HSDB 6793, MK906, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, CHEMBL710, N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide, BRN 4269024, L-652,931, Prosteride, (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide, 57GNO57U7G, CHEBI:5062, (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide, 17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one, C23H36N2O2, N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide, MFCD00869737, YM-152, 4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-, KS-1058, AK-72879, DSSTox_CID_625, N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide, N-(2-methyl-2-propyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide, DSSTox_RID_75699, DSSTox_GSID_20625, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, Eucoprost, Propeshia, (4AR,4BS,6AS,7S,9AS,9BS,11AR)-4A,6A-DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A-TETRADECAHYDRO-1H-INDENO[5,4-F]QUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-Butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,1, SMR000466304, SR-01000759414, Finasterid (TN), Prosteride (TN), Alternova (TN), NCGC00016965-01, Finpecia (TN), CPD000466304, Finasteride [USAN:USP:INN:BAN], Appecia (TN), CAS-98319-26-7, Finalo (TN), Finara (TN), Finast (TN), Fincar (TN), Gefina (TN), Finax (TN), Finasterid IVAX (TN), AC1L1MUF, Finasteride (USP/INN), D08IWD, AC1Q5L2C, SCHEMBL5509, BSPBio_000933, MLS000759404, MLS001165768, MLS001424046, Finasteride (JAN/USP/INN), SPBio_002854, BPBio1_001027, GTPL6818, DTXSID3020625, DBEPLOCGEIEOCV-WSBQPABSSA-N, 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, ACT02599, ZINC3782599, Tox21_110717, Tox21_201506, Tox21_302744, AN-615, BDBM50334788, MK 609, NSC741485, s1197, AKOS015894916, Tox21_110717_1, AB07586, BCP9000685, CCG-100937, CS-1767, DB01216, LS-7397, NC00187, NSC-741485, AJ-45596, BC200264, BR-72879, CC-28426, HY-13635, SC-12178, BCP0726000222, AB1008360, ST2419391, AB00513901, FT-0082891, D00321, J10122, X-2990, (17BETA-(N-TERT-BUTYLCARBAMOYL)-4-AZA-5ALPHA-ANDROST-1-EN-3-ONE, (5ALPHA,17BETA)-N-(1,1-DIMETHYLETHYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE, 1,(5ALPHA)-ANDROSTAN-4-AZA-3-ONE-17BETA-(N-TERT-BUTYL-CARBOXAMIDE), 4-azaandrost-1-ene-17-carboxamide, N -(1,1-dimethylethyl)-3-oxo-,(5(alpha),17(beta))-, 4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha, 17beta)-, 4-Azaandrost-1-ene-17-carboxamide,1-dimethylethyl)-3-oxo-, (5.alpha., 17.beta.)-, (1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-3-ene-14-carboxamide, (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, (4aR,4bS,6aS,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (4aR,6aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (4aR,6aS,11aR)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (4aR,6aS,7S)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (4aR,6aS,7S,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, (R)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, 4a,6a,9a-Trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid, 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide, N-tert-Butyl-3-oxo-4-aza-5|A-androst-1-en-17|A-carboxamide; N-(2-Methyl-2-propyl)-3-oxo-4-aza-5|A-androst-1-ene-17|A-carboxamide
Storage Store at room temperature, tightly sealed, away from heat, light and moisture.
Solubility DMSO, Ethanol
Organoleptic Profile Clear liquid
Physical Form Solution with Ethanol, PEG-400
Reports HPLC, USP 38
Terms The products we offer are intended for laboratory research use only.
Please familiarize yourself with our Terms & Conditions prior to ordering.